At similar age, an intravenous infusion of AAV9 particles packaging the SMN1 gene resulted in extended survival and improved motor functions in infants suffering for spinal muscular atrophy (Mendell et al., 2017). Here, SMN1 is linked to proximal spinal muscular atrophy.